Almirall Inks 'Transformational Deal' Buying Allergan's US Derma Portfolio

Buying Allergan's US dermatology portfolio will expand the Spanish group's platform in the world's largest dermatology market.

SC1808_Biz-Puzzle_1005619939_1200.jpg
Acquisition Part Of CEO's Plans For Rebuilding Almirall • Source: Shutterstock

Calling it a 'transformational deal' that will expand its presence in the all-important US market, Spain’s Almirall SA has bought Allergan PLC’s US dermatology portfolio in a transaction worth up to $650m.

The purchase, which is expected to close in the fourth quarter, includes an upfront cash payment of $550m and a...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Dermatological

More from Therapeutic Category